Philips announced a voluntary recall of some of its sleep and respiratory care devices in mid-June. The U.S. Food and Drug Administration (FDA) announced the…
Read MoreFirm News: Page 4
Category: Our Firm
Attorneys Gold and McDonough Speak at NJAJ
Attorneys Danielle Gold and Brendan McDonough, from our Drug and Medical Device Litigation unit, are presenting at the New Jersey Association for Justice (NJAJ)…
Category: Our Firm
U.S. News & World Report Recognizes W&L as “Best Law Firm”
Weitz & Luxenberg has been recognized by U.S. News & World Report and Best Lawyers magazine as one of the Best Law Firms in…
Category: Mesothelioma
New Mesothelioma Treatment Approved by FDA
The U.S. Food and Drug Administration (FDA) has approved a new drug therapy for treating mesothelioma which combines the use of two existing drugs.[cite…
Category: Our Firm
Weitz & Luxenberg Listed in New York Law Journal Top Verdicts Hall of Fame
According to the New York Law Journal, Weitz & Luxenberg has won more of the top New York products liability verdicts over the past…
Category: Drugs & Devices
Weitz & Luxenberg Taking Cases of Death, Serious Injury Linked to BD Alaris Recalls
Weitz & Luxenberg is taking cases of patient deaths, coma, or serious injury resulting from recalled BD Alaris Systems. Becton, Dickinson and Company (BD),…